ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 24 | June 11, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Subcommittee Vote: $950 Million Plus training DeVita Needs New Clinical Assistant

July 21, 1978

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

NCI’s Douglas Lowy and John Schiller Honored with National Medal

December 12, 2014

Bernard Fisher Sues Univ. of Pittsburgh And Its Attorney

July 15, 1994

Letter: A Modest Proposal To Abolish FDA

January 26, 1996